These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 17785018)
61. [Metabolic changes in PI-based HAART. Change to atazanavir: continued effectiveness with improved lipid profile]. MMW Fortschr Med; 2008 Apr; 150 Spec No 1():42-3. PubMed ID: 19024917 [No Abstract] [Full Text] [Related]
62. 96-week data from CASTLE study presented. Proj Inf Perspect; 2008 Dec; (47):3-4. PubMed ID: 19230058 [No Abstract] [Full Text] [Related]
63. The HIV-1 protease resistance mutation I50L is associated with resistance to atazanavir and susceptibility to other protease inhibitors in multiple mutational contexts. Sista P; Wasikowski B; Lecocq P; Pattery T; Bacheler L J Clin Virol; 2008 Aug; 42(4):405-8. PubMed ID: 18472298 [TBL] [Abstract][Full Text] [Related]
64. CASTLE analysis finds no benefit for once daily dosing. Proj Inf Perspect; 2008 Dec; (47):4. PubMed ID: 19226675 [No Abstract] [Full Text] [Related]
66. Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice. Moltó J; Santos JR; Valle M; Miranda C; Miranda J; Blanco A; Negredo E; Clotet B Ther Drug Monit; 2007 Oct; 29(5):648-51. PubMed ID: 17898658 [TBL] [Abstract][Full Text] [Related]
67. 96-week CASTLE data show similar efficacy results. AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840 [No Abstract] [Full Text] [Related]
68. Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes. Jones SP; Waitt C; Sutton R; Back DJ; Pirmohamed M AIDS; 2008 Jul; 22(11):1293-8. PubMed ID: 18580608 [TBL] [Abstract][Full Text] [Related]
69. Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients. Solas C; Gagnieu MC; Ravaux I; Drogoul MP; Lafeuillade A; Mokhtari S; Lacarelle B; Simon N Ther Drug Monit; 2008 Dec; 30(6):670-3. PubMed ID: 18806695 [TBL] [Abstract][Full Text] [Related]
70. Carotid plaque caused by usual risk factors. AIDS Patient Care STDS; 2005 Sep; 19(9):616. PubMed ID: 16245409 [No Abstract] [Full Text] [Related]
71. HIV protease inhibitors and hyperlipidemia: a fatty acid connection. Spector AA Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):7-9. PubMed ID: 16373621 [No Abstract] [Full Text] [Related]